Global (United States, European Union and China) Circulating Biomarker Market Research Report 2019-2025

Table of Contents

1 Circulating Biomarker Market Overview

• 1.1 Product Overview and Scope of Circulating Biomarker
• 1.2 Circulating Biomarker Segment by Type
  • 1.2.1 Global Circulating Biomarker Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Circulating DNA
  • 1.2.3 Circulating Tumor Cells
  • 1.2.4 Other
• 1.3 Circulating Biomarker Segment by Application
  • 1.3.1 Circulating Biomarker Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Medical Research Center
  • 1.3.4 Others
• 1.4 Global Circulating Biomarker Market Size Estimates and Forecasts
  • 1.4.1 Global Circulating Biomarker Revenue 2015-2026
  • 1.4.2 Global Circulating Biomarker Sales 2015-2026
  • 1.4.3 Circulating Biomarker Market Size by Region: 2020 Versus 2026

2 Global Circulating Biomarker Market Competition by Manufacturers

• 2.1 Global Circulating Biomarker Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Circulating Biomarker Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Circulating Biomarker Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Circulating Biomarker Manufacturing Sites, Area Served, Product Type
• 2.5 Circulating Biomarker Market Competitive Situation and Trends
  • 2.5.1 Circulating Biomarker Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Circulating Biomarker Players (Opinion Leaders)

3 Circulating Biomarker Retrospective Market Scenario by Region

• 3.1 Global Circulating Biomarker Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Circulating Biomarker Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Circulating Biomarker Market Facts & Figures by Country
  • 3.3.1 North America Circulating Biomarker Sales by Country
  • 3.3.2 North America Circulating Biomarker Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Circulating Biomarker Market Facts & Figures by Country
  • 3.4.1 Europe Circulating Biomarker Sales by Country
  • 3.4.2 Europe Circulating Biomarker Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Circulating Biomarker Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Circulating Biomarker Sales by Region
  • 3.5.2 Asia Pacific Circulating Biomarker Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Circulating Biomarker Market Facts & Figures by Country
  • 3.6.1 Latin America Circulating Biomarker Sales by Country
  • 3.6.2 Latin America Circulating Biomarker Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Circulating Biomarker Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Circulating Biomarker Sales by Country
  • 3.7.2 Middle East and Africa Circulating Biomarker Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Circulating Biomarker Historic Market Analysis by Type

• 4.1 Global Circulating Biomarker Sales Market Share by Type (2015-2020)
• 4.2 Global Circulating Biomarker Revenue Market Share by Type (2015-2020)
• 4.3 Global Circulating Biomarker Price Market Share by Type (2015-2020)
• 4.4 Global Circulating Biomarker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Circulating Biomarker Historic Market Analysis by Application

• 5.1 Global Circulating Biomarker Sales Market Share by Application (2015-2020)
• 5.2 Global Circulating Biomarker Revenue Market Share by Application (2015-2020)
• 5.3 Global Circulating Biomarker Price by Application (2015-2020)

6 Company Profiles and Key Figures in Circulating Biomarker Business

• 6.1 Abbott Laboratories
  • 6.1.1 Corporation Information
  • 6.1.2 Abbott Laboratories Description, Business Overview and Total Revenue
  • 6.1.3 Abbott Laboratories Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Abbott Laboratories Products Offered
  • 6.1.5 Abbott Laboratories Recent Development
• 6.2 Becton, Dickinson and Company
  • 6.2.1 Becton, Dickinson and Company Circulating Biomarker Production Sites and Area Served
  • 6.2.2 Becton, Dickinson and Company Description, Business Overview and Total Revenue
  • 6.2.3 Becton, Dickinson and Company Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Becton, Dickinson and Company Products Offered
  • 6.2.5 Becton, Dickinson and Company Recent Development
• 6.3 GE Healthcare
  • 6.3.1 GE Healthcare Circulating Biomarker Production Sites and Area Served
  • 6.3.2 GE Healthcare Description, Business Overview and Total Revenue
  • 6.3.3 GE Healthcare Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 GE Healthcare Products Offered
  • 6.3.5 GE Healthcare Recent Development
• 6.4 Epigenomics AG
  • 6.4.1 Epigenomics AG Circulating Biomarker Production Sites and Area Served
  • 6.4.2 Epigenomics AG Description, Business Overview and Total Revenue
  • 6.4.3 Epigenomics AG Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Epigenomics AG Products Offered
  • 6.4.5 Epigenomics AG Recent Development
• 6.5 Agilent Technologies
  • 6.5.1 Agilent Technologies Circulating Biomarker Production Sites and Area Served
  • 6.5.2 Agilent Technologies Description, Business Overview and Total Revenue
  • 6.5.3 Agilent Technologies Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Agilent Technologies Products Offered
  • 6.5.5 Agilent Technologies Recent Development
• 6.6 Biocept
  • 6.6.1 Biocept Circulating Biomarker Production Sites and Area Served
  • 6.6.2 Biocept Description, Business Overview and Total Revenue
  • 6.6.3 Biocept Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Biocept Products Offered
  • 6.6.5 Biocept Recent Development
• 6.7 Affymetrix
  • 6.6.1 Affymetrix Circulating Biomarker Production Sites and Area Served
  • 6.6.2 Affymetrix Description, Business Overview and Total Revenue
  • 6.6.3 Affymetrix Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Affymetrix Products Offered
  • 6.7.5 Affymetrix Recent Development
• 6.8 Fluxion Biosciences
  • 6.8.1 Fluxion Biosciences Circulating Biomarker Production Sites and Area Served
  • 6.8.2 Fluxion Biosciences Description, Business Overview and Total Revenue
  • 6.8.3 Fluxion Biosciences Circulating Biomarker Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Fluxion Biosciences Products Offered
  • 6.8.5 Fluxion Biosciences Recent Development

7 Circulating Biomarker Manufacturing Cost Analysis

• 7.1 Circulating Biomarker Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Circulating Biomarker
• 7.4 Circulating Biomarker Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Circulating Biomarker Distributors List
• 8.3 Circulating Biomarker Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Circulating Biomarker Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Circulating Biomarker by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Circulating Biomarker by Type (2021-2026)
• 10.2 Circulating Biomarker Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Circulating Biomarker by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Circulating Biomarker by Application (2021-2026)
• 10.3 Circulating Biomarker Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Circulating Biomarker by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Circulating Biomarker by Region (2021-2026)
• 10.4 North America Circulating Biomarker Estimates and Projections (2021-2026)
• 10.5 Europe Circulating Biomarker Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Circulating Biomarker Estimates and Projections (2021-2026)
• 10.7 Latin America Circulating Biomarker Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Circulating Biomarker Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List